MedPath

PARASTERNAL BLOCKADE

Phase 3
Completed
Conditions
Parasternal Block
Cardiac Surgery
Serum Lactate
Interventions
Procedure: parasternal block
Diagnostic Test: Lactate serum level
Registration Number
NCT06608290
Lead Sponsor
Instituto Mexicano del Seguro Social
Brief Summary

Parasternal blockade has been related to a reduction of the postoperative inflammatory response, by inhibition of the stress response, leading to a better prognosis. Increased lactate level is a useful parameter in identifying patients at risk of postoperative morbidity and mortality. The objective was to evaluate the association between parasternal blockade and serum lactate level in patients undergoing cardiac surgery, both trans- and post-anesthesia. 86 patients between 60-70 years of age participated. An association was found between the application of parasternal blockade in cardiac surgery and the presence of lower trans and postanesthetic serum lactate levels.

Detailed Description

An analytical cross-sectional study in adult patients who underwent elective cardiac surgery. A total sample of 86 patients was obtained, 43 in the case group and 43 in the control group. Adult patients older than 18 years, of either sex, with ASA II-III, patients who underwent cardiac surgery with median sternotomy and use of cardiopulmonary bypass were included.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
86
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Blockadeparasternal blockIn patients which parasternal block has been applied
BlockadeLactate serum levelIn patients which parasternal block has been applied
ControlLactate serum levelIn patients which parasternal block has not been applied
Primary Outcome Measures
NameTimeMethod
Lactate serum levels24 Hours

Blood samples were taken to identify serum lactate levels greater than 2 mmol/l and those that remained below this limit.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Unidad de Investigación Biomédica 02, Unidad Médica de alta especialidad, Hospital de Especialidades Centro Médico Nacional de Occidente, Instituto Mexicano del Seguro Social, Guadalajara 44329, México

🇲🇽

Guadalajara, Jalisco, Mexico

© Copyright 2025. All Rights Reserved by MedPath